UNSPSC 85821305: Measurement of gastrointestinal secretion, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a measurement intervention or procedure to measurement of gastrointestinal secretion, via natural or artificial opening endoscopic. This measurement intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 4A0B8GZ

UNSPSC 85821305 Measurement of gastrointestinal secretion via natural or artificial opening endoscopic is a Commodity code that covers the invasive diagnostic and therapeutic procedures used to evaluate gastrointestinal tract conditions. State and local governments procure these services primarily through health departments, public hospital systems, and state-supported living centers that serve vulnerable or institutionalized populations requiring clinical assessment of digestive and related disorders. The recent opportunities block shows minimal activity directly aligned with this Commodity code; most posted solicitations address broader healthcare delivery (virtual urgent care, medical director services, employee health clinics) or unrelated service lines (cancer registry, retinal screening, occupational health evaluations). One exception is the Nevada Health Authority's PACE program RFP, which encompasses multidisciplinary senior care including diagnostic procedures, but the posted opportunity does not isolate endoscopic procedures as a distinct line item. The code itself carries narrow clinical specificity—measurement of gastrointestinal secretion through endoscopy—yet the recent opportunities block documents no targeted state or local RFP, RFQ, IFB, or ITB for this service line specifically, suggesting low current procurement velocity in this commodity area.

State and local bodies that do purchase endoscopic diagnostic services typically bundle them within larger clinical service contracts or facility-level medical directorships rather than solicit them as standalone commodities. Geographic activity is scattered across multiple states (California, Nevada, Georgia, Colorado, Kansas, Florida, and others) represented in the opportunities block, but none of those recent solicitations name gastrointestinal secretion measurement via endoscopy as a discrete procurement need. The mismatch between the Commodity code's narrow scope and the recent opportunities block suggests either that this category sees episodic or embedded procurement activity not captured in standalone RFPs, or that state and local bodies structure similar clinical services under higher-tier Family or Class codes encompassing broader diagnostic and therapeutic service portfolios. Absent evidence of recent standalone opportunities, pursuit of this code should focus on pre-bid relationship building with state health departments, public hospital systems, and institutional care operators that maintain gastroenterology or internal medicine programs, while monitoring for future RFPs that may decompose broader clinical service procurements into component diagnostic lines.